DW Healthcare Partners

10 articles about DW Healthcare Partners

• DWHP Announces Extension of The Expiration Time of Its Tender Offer

  1/22/2021

  DW Healthcare Partners V, L.P., announced that it is extending the expiration time of its previously announced cash tender offer in the Offer to Purchase dated December 21, 2020 for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes to 11:59 p.m., New York City time, on January 28, 2021.

• DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex

  12/28/2020

   DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced today the closing of its previously disclosed sale of Z-Medica ("Z-Medica" or "the Company") to Teleflex Incorporated (NYSE: TFX) ("Teleflex"). Z-Medica, a portfolio company of DW Healthcare Partners and Linden Capital Partners ("Linden"), is a le

• DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd

  12/21/2020

   DW Healthcare Partners V, L.P. ("Purchaser"), announced today that it has commenced a cash tender offer for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S. $0.40 per share, net to the seller in cash without interest and less applicable wi

• DW Healthcare Partners Announces Sale of Caregiver, Inc.

  7/28/2020

  DW Healthcare Partners ("DWHP"), a healthcare–focused private equity firm, announced the sale of its portfolio company, Caregiver, Inc. ("Caregiver").  Caregiver provides intermediate, home and residential care to individuals with intellectual or developmental disabilities.

• DWHP Announces 2019 Staff Promotions

  8/21/2019

  DW Healthcare Partners, a healthcare-focused private equity firm, announced three promotions.

• DW Healthcare Partners Raises Fifth Fund with $610 Million of Capital Commitments

  7/23/2019

  DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, announced the closing of its fifth fund.

• DW Healthcare Partners Announces Sale of Reliant Rehabilitation

  9/13/2018

  Reliant is one of the leading providers of contract therapy services to post-acute facilities in the United States.

• DW Healthcare Partners Announces Investment in 360 Behavioral Health

  8/20/2018

  DW Healthcare Partners has invested in California Psychcare

• DW Healthcare Partners Invests in Med-Pharmex, Inc.

  5/1/2013

• DW Healthcare Partners Forms Best in Class Organization With ClinPro and Pacific Data Designs, Inc.

  11/7/2008